Glucose Health, Inc.
GLUCOTCConsumer Defensive● Active
$0.46
+$0.02(+4.55%)
Market Cap$7825520
P/E Ratio—
52W High$0.674
52W Low$0.02
Glucose Health, Inc. (GLUC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GLUC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.34M | $0.38M | $0.53M | $1.07M | $0.95M |
| Cost of Revenue | $0.22M | $0.31M | $0.32M | $0.62M | $0.54M |
| Gross Profit | $0.12M | $0.08M | $0.22M | $0.46M | $0.41M |
| Gross Margin %(computed) | 35.00% | 19.67% | 40.35% | 42.58% | 43.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.01M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.14M |
| Total Operating Expenses | $0.32M | $0.38M | $0.64M | $1.02M | $0.75M |
| Operating Income | ($0.20M) | ($0.31M) | ($0.42M) | ($0.56M) | ($0.34M) |
| Operating Margin %(computed) | -58.65% | -79.82% | -78.91% | -52.40% | -35.24% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.04M | $0.01M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($0.23M) | ($0.32M) | ($0.42M) | ($0.56M) | ($0.34M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.23M) | ($0.32M) | ($0.42M) | ($0.56M) | ($0.34M) |
| Net Margin %(computed) | -67.72% | -82.26% | -78.91% | -52.40% | -35.54% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.03 | $-0.03 | $-0.05 | $-0.03 |
| Wtd Avg Shares | 17.85M | 17.03M | 17.00M | 14.49M | 12.88M |
| EBITDA | ($0.20M) | ($0.31M) | ($0.42M) | ($0.56M) | ($0.34M) |
| EBITDA Margin %(computed) | -57.88% | -79.53% | -78.91% | -52.40% | -35.24% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Glucose Health, Inc. data
About Glucose Health, Inc. (GLUC) Income Statement
Glucose Health, Inc. (GLUC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GLUC reported revenue of $0.00B, gross profit of $0.00B (gross margin 35.00%), and net income of ($0.00B) — a net profit margin of -67.72%.
Frequently asked questions
GLUC · 4 questionsGlucose Health, Inc. (GLUC) reported revenue of $0.00B for 2025, down 11.3% year-over-year.
GLUC revenueGLUC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09